Home > Insider Trading > Filing (0001209191-14-060754)

Filing Details

Accession Number:: 0001209191-14-060754
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-10-01 21:03:03
Reporting Period:: 2014-09-29

Filing Date:: 2014-10-01
Accepted Time:: 2014-10-01 21:03:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1157602	Vitae Pharmaceuticals Inc	VTAE	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1135669	Prospect Venture Partners Ii Lp	C/O Prospect Venture Partners 435 Tasso Street, Suite 200 Palo Alto CA 94301	No	No	Yes	No
1162055	Prospect Venture Partners Lp	C/O Prospect Venture Partners 435 Tasso Street, Suite 200 Palo Alto CA	No	No	Yes	No
1162056	Prospect Management Co Llc	C/O Prospect Venture Partners 435 Tasso Street, Suite 200 Palo Alto CA 94301	No	No	Yes	No
1162057	Prospect Management Co Ii Llc	C/O Prospect Venture Partners 435 Tasso Street, Suite 200 Palo Alto CA 94301	No	No	Yes	No
1162059	C Russell Hirsch	C/O Prospect Venture Partners 435 Tasso Street, Suite 200 Palo Alto CA 94301	No	No	Yes	No
1162060	David Schnell	C/O Prospect Venture Partners 435 Tasso Street, Suite 200 Palo Alto CA 94301	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-09-29	261,977	$0.00	293,498	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-09-29	261,977	$0.00	293,498	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-09-29	102,301	$0.00	395,799	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-09-29	1,530,269	$0.00	1,823,767	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-09-29	76,949	$0.00	1,900,716	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-09-29	671,807	$8.00	2,572,523	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-2 Preferred Stock	Disposition	2014-09-29	173,912	$0.00	261,977	$0.00
Common Stock	Series A-2 Preferred Stock	Disposition	2014-09-29	173,912	$0.00	261,977	$0.00
Common Stock	Series B Preferred Stock	Disposition	2014-09-29	102,301	$0.00	102,301	$0.00
Common Stock	Series B Preferred Stock	Disposition	2014-09-29	1,530,269	$0.00	1,530,269	$0.00
Common Stock	Series C Preferred Stock	Disposition	2014-09-29	76,949	$0.00	76,949	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	31,520	Indirect	See Footnote
Common Stock	31,520	Indirect	See Footnote

Footnotes

Each outstanding share of Series A-2 Preferred Stock automatically converted on a 1:1.50638118 basis into the Issuer's common stock, immediately prior to the Issuer's initial public offering, for no additional consideration.
The reportable securities are owned by Prospect Venture Partners, L.P. ("PVP"). Prospect Management Co., L.L.C. ("PMC") is the general partner of PVP. David Schnell ("Schnell") is the managing member of PMC. Each of PMC and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
The reportable securities are owned by Prospect Venture Partners II, L.P. ("PVP II"). Prospect Management Co. II, L.L.C. ("PMC II") is the general partner of PVP II. Russell Hirsch ("Hirsch") and Schnell are the managing members of PMC II. Each of PMC II, Hirsch and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted on a 1:1 basis into the Issuer's common stock, immediately prior to the Issuer's initial public offering, for no additional consideration.
The reportable securities are owned by PVP, as Nominee. PMC is the general partner of PVP. Schnell is the managing member of PMC. Each of PMC and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
The reportable securities are owned by PVP II, as Nominee. PMC II is the general partner of PVP II. Hirsch and Schnell are the managing members of PMC II. Each of PMC II, Hirsch and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.